Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis.
暂无分享,去创建一个
J. Reginster | H. Genant | B. Mitlak | S. Ish-shalom | R. Prince | J. Zanchetta | R. Neer | E. Eriksen | C. Arnaud | G. Gaich | A. Hodsman | O. Wang | B. Mitlak
[1] I. Reid,et al. Long-term effects of calcium supplementation on bone loss and fractures in postmenopausal women: a randomized controlled trial. , 1995, The American journal of medicine.
[2] J Dequeker,et al. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group. , 1995, The New England journal of medicine.
[3] D. Drost,et al. Bone densitometric and histomorphometric responses to sequential human parathyroid hormone (1-38) and salmon calcitonin in osteoporotic patients. , 1991, Bone and mineral.
[4] L. Melton,et al. Survival after the diagnosis of hyperparathyroidism: a population-based study. , 1998, The American journal of medicine.
[5] G E Dallal,et al. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. , 1997, The New England journal of medicine.
[6] A. Lane,et al. Treatment of Postmenopausal Osteoporosis with Transdermal Estrogen , 1992, Annals of Internal Medicine.
[7] S. Ott,et al. Calcitriol treatment is not effective in postmenopausal osteoporosis. , 1989, Annals of internal medicine.
[8] S. Cummings,et al. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures , 1996, The Lancet.
[9] Ying Lu,et al. Dual X‐ray absorptiometry quality control: Comparison of visual examination and process‐control charts , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[10] H. Genant,et al. Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis. , 1990, The New England journal of medicine.
[11] H. Adami,et al. Increased risk of malignant diseases after surgery for primary hyperparathyroidism. A nationwide cohort study. , 1988, American journal of epidemiology.
[12] F Duboeuf,et al. Vitamin D3 and calcium to prevent hip fractures in elderly women. , 1992, The New England journal of medicine.
[13] L. Bouter,et al. Vitamin D Supplementation and Fracture Incidence in Elderly Persons , 1996, Annals of Internal Medicine.
[14] M. Nevitt,et al. Vertebral fracture assessment using a semiquantitative technique , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[15] W. Mysiw,et al. Intermittent cyclical etidronate treatment of postmenopausal osteoporosis. , 1990, The New England journal of medicine.
[16] R. Lindsay,et al. PREVENTION OF SPINAL OSTEOPOROSIS IN OOPHORECTOMISED WOMEN , 1980, The Lancet.
[17] A. LaCroix,et al. Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial. , 1998, JAMA.
[18] J. Hock,et al. Effects of continuous and intermittent administration and inhibition of resorption on the anabolic response of bone to parathyroid hormone , 1992, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[19] G. Spears,et al. Treatment of postmenopausal osteoporosis with calcitriol or calcium. , 1992, The New England journal of medicine.
[20] H K Genant,et al. Comparative calibration without a gold standard. , 1997, Statistics in medicine.
[21] R. Turner. Mice, Estrogen, and Postmenopausal Osteoporosis , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[22] J. Heersche,et al. Parathyroid hormone stimulates the bone apposition rate independently of its resorptive action: differential effects of intermittent and continuous administration. , 1982, Endocrinology.
[23] R. Lindsay,et al. Anabolic actions of parathyroid hormone on bone. , 1993, Endocrine reviews.
[24] J. Parsons,et al. Effects of two treatment regimes with synthetic human parathyroid hormone fragment on bone formation and the tissue balance of trabecular bone in greyhounds. , 1983, Endocrinology.